{
    "clinical_study": {
        "@rank": "162930", 
        "arm_group": [
            {
                "arm_group_label": "Renal sympathetic denervation", 
                "arm_group_type": "Experimental", 
                "description": "Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)"
            }, 
            {
                "arm_group_label": "Sham procedure", 
                "arm_group_type": "Sham Comparator", 
                "description": "Sham procedure mimicking the renal sympathetic denervation procedure in the experimental arm"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine the benefit of renal sympathetic denervation in\n      patients with mild refractory hypertension"
        }, 
        "brief_title": "Renal Sympathetic Denervation in Mild Refractory Hypertension", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Refractory Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Refractory hypertension: 3 or more antihypertensive agents of different classes\n             (including a diuretic) at optimal dosage without change in the 4 weeks preceding\n             randomization\n\n          -  Systolic blood pressure of 135-149 and/or diastolic blood pressure of 90-94 mmHg\n             (ABPM mean daytime values)\n\n          -  No change in blood pressure medication within 6 months after randomization\n\n          -  Age 18 to 75 years\n\n          -  Informed consent\n\n        Exclusion Criteria:\n\n          -  Blood pressure outside range mentioned above\n\n          -  Renal, aortic or pelvic anatomy unsuited for renal sympathetic denervation\n\n          -  Estimated glomerular filtration rate <45 mL/min/1.73 m\u00b2 (modification of diet in\n             renal disease formula)\n\n          -  Unstable angina pectoris\n\n          -  Myocardial infarction within 6 months prior to randomization\n\n          -  Planned surgery or cardiovascular intervention within 6 months after randomization\n\n          -  Severe heart valve disease\n\n          -  Severe comorbidities with limited life expectancy\n\n          -  Pregnancy\n\n          -  Participation in another trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01656096", 
            "org_study_id": "RSD-Leipzig"
        }, 
        "intervention": [
            {
                "arm_group_label": "Renal sympathetic denervation", 
                "intervention_name": "Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Sham procedure", 
                "intervention_name": "Sham procedure", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 5, 2013", 
        "location": {
            "contact": {
                "email": "stdesch@web.de", 
                "last_name": "Steffen Desch, MD", 
                "phone": "0049341865", 
                "phone_ext": "0"
            }, 
            "facility": {
                "address": {
                    "city": "Leipzig", 
                    "country": "Germany", 
                    "zip": "04289"
                }, 
                "name": "University of Leipzig Heart Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Renal Sympathetic Denervation in Patients With Mild Refractory Hypertension", 
        "overall_contact": {
            "email": "stdesch@web.de", 
            "last_name": "Steffen Desch, MD", 
            "phone": "0049341865", 
            "phone_ext": "0"
        }, 
        "overall_official": {
            "affiliation": "University of Leipzig", 
            "last_name": "Steffen Desch, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in systolic blood pressure (ABPM mean value)", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01656096"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Leipzig", 
            "investigator_full_name": "Steffen Desch, MD", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Leipzig", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Leipzig", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}